» Articles » PMID: 35844564

Immune Cell-Derived Extracellular Vesicles in the Face of Pathogenic Infections

Overview
Journal Front Immunol
Date 2022 Jul 18
PMID 35844564
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular Vesicles (EVs) are a collection of vesicles released from cells that play an important role in intercellular communication. Microbial infections are known as one of the major problems in the medical field. Considering the increasing resistance of strains to routine drug treatments, the need for new therapies seems to be more than ever. Recent studies have shown that the EVs released from immune cells during microbial infections had anti-microbial effects or were able to induce neighbouring cells to display anti-microbial effects. This mini-review aimed to explore the latest studies on immune cell-derived EVs in viral, bacterial, fungal, and parasitic infections. Review of the literature demonstrated that specific cargos in EVs were involved in the fight against pathogenic infections. Additionally, the transport of appropriate bioactive molecules including miRNAs, mRNAs, and proteins EVs could mediate the anti-microbial process. Thus, it could be a proof-of-principle that therapeutic approaches based on EVs derived from immune cells could offer a promising path forward, which is still in early stages and needs further assessments.

Citing Articles

Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation.

Alfred M, Ochola L, Okeyo K, Bae E, Ogongo P, Odongo D Front Cell Infect Microbiol. 2025; 15:1521265.

PMID: 40041145 PMC: 11876127. DOI: 10.3389/fcimb.2025.1521265.


Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential.

Abida , Alhuthali H, Alshehri J, Alkathiri A, Almaghrabi R, Alsaeed S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702600 DOI: 10.1007/s00210-024-03702-7.


Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.

Adugna A, Muche Y, Melkamu A, Jemal M, Belew H, Amare G Heliyon. 2024; 10(14):e34288.

PMID: 39100497 PMC: 11295980. DOI: 10.1016/j.heliyon.2024.e34288.


Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools.

Kanannejad Z, Arab S, Soleimanian S, Mazare A, Kheshtchin N Immun Inflamm Dis. 2024; 12(6):e1325.

PMID: 38934401 PMC: 11209551. DOI: 10.1002/iid3.1325.


Exploration of altered miRNA expression and function in MSC-derived extracellular vesicles in response to hydatid antigen stimulation.

Wang X, Mijiti W, Jia Q, Yi Z, Ma J, Zhou Z Front Microbiol. 2024; 15:1381012.

PMID: 38601938 PMC: 11004373. DOI: 10.3389/fmicb.2024.1381012.

References
1.
Segura E, Nicco C, Lombard B, Veron P, Raposo G, Batteux F . ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood. 2005; 106(1):216-23. DOI: 10.1182/blood-2005-01-0220. View

2.
Coakley G, McCaskill J, Borger J, Simbari F, Robertson E, Millar M . Extracellular Vesicles from a Helminth Parasite Suppress Macrophage Activation and Constitute an Effective Vaccine for Protective Immunity. Cell Rep. 2017; 19(8):1545-1557. PMC: 5457486. DOI: 10.1016/j.celrep.2017.05.001. View

3.
Schnitzer J, Berzel S, Fajardo-Moser M, Remer K, Moll H . Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine. 2010; 28(36):5785-93. DOI: 10.1016/j.vaccine.2010.06.077. View

4.
Wu W, Wu D, Yan W, Wang Y, You J, Wan X . Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p. J Infect Dis. 2020; 223(4):686-698. DOI: 10.1093/infdis/jiaa399. View

5.
Radomski N, Karger A, Franzke K, Liebler-Tenorio E, Jahnke R, Matthiesen S . -Infected Dendritic Cells Communicate with NK Cells via Exosomes To Activate Antibacterial Immunity. Infect Immun. 2019; 88(1). PMC: 6921653. DOI: 10.1128/IAI.00541-19. View